Skip to content

Inherited Thromophilia and Thrombotic Risks in Inflammatory Bowel Disease During Activity and Remission

Inherited Thrombophilia and Thrombotic Risks in Inflammatory Bowel Disease During Activity and Remission

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06691451
Enrollment
93
Registered
2024-11-15
Start date
2024-11-30
Completion date
2027-03-31
Last updated
2024-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Diseases

Brief summary

Inherited thombopllia and thrombotic risks in inflammatory bowel Disease during activity and remission

Detailed description

Inflammatory bowel diseases (IBD) are systemic conditions characterized by multiple intestinal and extra-intestinal manifestations related to the associated chronic inflammatory state. Among their diverse extra-intestinal complications, venous thromboembolism (VTE) remains one of the most under recognized causes of morbidity and mortality in these patients, highlighting the need for a better understanding of the underlying mechanism of hypercoagulability, in addition to the role of acquired and inherited risk factors that further increase the risk of thrombosis with its impact on patients' outcomes.\[1, 2\]

Interventions

None listed

Sponsors

Assiut University
CollaboratorOTHER
Asmaa mohammed abdelaal abdelaal
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age (18yrs - 65yrs) both sex

Exclusion criteria

* Presence of acquired cause (pregnancy, recent surgery, history of drug, History of malignant Disease, History of blood or blood product transfusion in last 4 weeks)

Design outcomes

Primary

MeasureTime frameDescription
Comparison between the number of IBD patients with tendency to thrombosis in cases of activity-Baseline-investigate the presence of multiple mutations associated with IBD patients with or without vascular complications.

Contacts

Primary ContactAsmaa Mohammed Abdelaal, Master
Asmaamohammedabdelaal0098@gmail.com01066239562

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026